1. Department of Rheumatology, Saint‐Antoine Hospital, Centre de Recherche Saint‐Antoine, Paris Inserm UMRS 938, Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Paris, France, Immunology, Immunopathology, Immunotherapy I3 Lab, Inserm URMS 959, Pitié‐Salpêtrière Hospital, Paris, France, and Bakar Computational Health Science Institute University of California San Francisco
2. Immunology, Immunopathology, Immunotherapy I3 Lab, Inserm URMS 959 Pitié‐Salpêtrière Hospital Paris France
3. Department of Rheumatology, Ambroise Paré Hospital, UMR 1173 INSERM, Université de Versailles Saint‐Quentin Assistance Publique–Hôpitaux de Paris Boulogne France
4. Department of Rheumatology, Saint‐Antoine Hospital, Centre de Recherche Saint‐Antoine, Paris Inserm UMRS 938 Sorbonne Université, Assistance Publique–Hôpitaux de Paris Paris France
5. Immunology, Immunopathology, Immunotherapy I3 Lab, Inserm URMS 959, Pitié‐Salpêtrière Hospital and Biotherapy (CIC‐BTi) and Inflammation Immunopathology‐Biotherapy Department (i2B) Assistance Publique–Hôpitaux de Paris Paris France
6. Bakar Computational Health Science Institute University of California San Francisco
7. Department of Rheumatology Université de Montpellier Montpellier France
8. Department of Rheumatology, Cochin Hospital, Inserm UMR 1153, Université de Paris Assistance Publique–Hôpitaux de Paris Paris France
9. Department of Rheumatology, Lariboisière Hospital, INSERM U1132 Université de Paris, Assistance Publique–Hôpitaux de Paris Paris France